Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

by on 17 d'octubre de 2022 with No hi ha comentaris
  • Borazanci, E., Schram, A. M., Garralda, E., Brana, I., Vieito Villar, M., Spreafico, A., . . . Tabernero, J. (2022). Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. ESMO Open, 7(4). https://doi.org/10.1016/j.esmoop.2022.100530

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *